Inactive/Delisted stock
Anebulo Pharmaceuticals Stock (NASDAQ:ANEB)
Previous Close
$2.31
52W Range
$0.80 - $3.42
50D Avg
$2.47
200D Avg
$1.68
Market Cap
$94.49M
Avg Vol (3M)
$425.37K
Beta
-0.89
Div Yield
-
ANEB Company Profile
Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing and commercializing treatments for people suffering from acute cannabinoid intoxication and substance addiction. Its lead product candidate is ANEB-001, a small molecule cannabinoid receptor antagonist to treat cannabinoid intoxication and overdose. The company was incorporated in 2020 and is based in Lakeway, Texas.